Industry Developments

Underlining its commitment to emerging markets, Philips has acquired Mumbai-based Alpha X-Ray Technologies for an undisclosed sum. The transaction gives the Dutch company an increased... 2008-09-08

News: Swiss pharmaceutical company Roche's oral chemotherapy drug, Xeloda (capecitabine), has been approved by China's State Food and Drug Administration (SFDA) for the treatment... 2008-09-05

The cautious nature of Japan's regulatory regime has been demonstrated once again. A government panel has recommended approval of thalidomide for multiple myeloma ten years after... 2008-08-28

French firm Servier has launched Coralan (ivabradine) in Singapore for the treatment of angina. Because of the city state's affluence and the increasing burden of cardiovascular disease,... 2008-08-13

Boehringer Ingleheim is outpacing the South Korean over-the-counter (OTC) medicine sector. The German company's sales increased 1.9% in the first half of 2008, while most other competitors... 2008-08-13

Merck & Co has launched its integrase inhibitor for HIV Isentress (raltegravir) in Japan through its local subsidiary Banyu.

In an effort to penetrate emerging markets, UK specialty drugmaker Sinclair Pharma has contracted Mumbai-based Wockhardt to distribute four of its products in India. The deal runs... 2008-06-30

Attracted by significant growth opportunities, US-based healthcare company Aetna has opened a representative office in Shanghai, which is the first step in offering insurance policies... 2008-06-30

China is the premier investment focus for German firm Bayer, much like the US was in the 1990s. Indeed, Bayer believes it can supplant AstraZeneca as the number one drugmaker in the... 2008-06-23

India's Plethico Pharmaceuticals is targeting acquisitions in the US and Brazil in order to expand its Americas over-the-counter (OTC) and nutraceuticals businesses, according to... 2008-06-20